In the US, Valcyte (valganciclovir systemic) is a member of the drug class purine nucleosides and is used to treat CMV Retinitis and Cytomegalovirus Infection.
US matches:
- Valcyte
- Valcyte Solution
UK matches:
- Valcyte 450mg film-coated tablets (SPC)
- Valcyte Powder for Oral Solution (SPC)
Ingredient matches for Valcyte
Valganciclovir
Valganciclovir is reported as an ingredient of Valcyte in the following countries:
- Norway
- Singapore
- South Africa
Valganciclovir hydrochloride (a derivative of Valganciclovir) is reported as an ingredient of Valcyte in the following countries:
- Australia
- Austria
- Belarus
- Belgium
- Brazil
- Canada
- Chile
- China
- Colombia
- Croatia (Hrvatska)
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- Germany
- Greece
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Ireland
- Israel
- Kenya
- Kuwait
- Latvia
- Lithuania
- Luxembourg
- Malaysia
- Mexico
- Netherlands
- New Zealand
- Oman
- Philippines
- Poland
- Portugal
- Puerto Rico
- Romania
- Saudi Arabia
- Serbia
- Singapore
- Slovakia
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Taiwan
- Thailand
- Trinidad & Tobago
- Turkey
- United Kingdom
- United States
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment